Hormone Therapy Shows Little Benefit Against Prostate Cancer
July 10th, 2008 Posted in hormone therapySurvival rates no different than ‘watchful waiting,’ study shows.
An increasingly common therapy used for localized prostate cancer may not bestow any survival benefits on the patient beyond those seen with a simple “wait-and-see” approach.
Men taking androgen deprivation therapy, which shuts off male hormones that can promote tumor growth, even had a slightly lower prostate cancer-specific survival rate.
[ read more ]